SUSTAINED VIROLOGIC RESPONSE [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
Improves [qlco]    
Survival [acty]    
Chronic hepatitis C [dsyn]    
Multicenter Study [resa]    
TAIWAN [geoa]    
Long Term [tmco]    
Benefit [qnco]    
Chronic hepatitis C [dsyn]    
Patients [podg]    
Treated [ftcn]    
Combination Therapy [topp]    
Evaluate [hlca]    
Long-Term Effects [phpr]    
Combination Therapy [topp]    
Reducing [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Mortality [qnco]    
Patients [podg]    
chronic Hepatitis C virus infection [dsyn]    
Risk Factors [qnco]    
Methods [inpr]    
Patients [podg]    
BIOPSY [diap]    
Proven [qlco]    
Including [ftcn]    
Receive [qlco]    
Based [ftcn]    
therapy [ftcn]    
Combination Therapy [topp]    
untreated [fndg]    
control [qlco]    
REGIONAL [spco]    
Core [spco]    
TAIWAN [geoa]    
Retrospective Cohort Study [resa]    
prospective [resa]    
HEPATOCELLULAR CARCINOMA [neop]    
Survival [acty]    
YEARS [tmco]    
In [qnco]    
Treated [ftcn]    
untreated [fndg]    
Patients [podg]    
Proportional [qlco]    
Hazards [qlco]    
Regression [patf]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
untreated [fndg]    
Treated [ftcn]    
Groups [idcn]    
Cumulative Survival Rate [qnco]    
untreated [fndg]    
Treated [ftcn]    
Groups [idcn]    
LOWER [spco]    
Incidences [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Mortality [qnco]    
Observed [ftcn]    
Sustained [ftcn]    
Virological [ftcn]    
Combination [qlco]    
Compared [acty]    
untreated [fndg]    
Patients [podg]    
Hepatitis C virus genotype 1 [virs]    
Patients [podg]    
Significantly high [qnco]    
Incidences [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Genotype [orga]    
{Non-patient} [clna]    
Pre-existing [qlco]    
CIRRHOSIS [dsyn]    
Response [orga]    
Hepatitis C virus genotype 1 [virs]    
HEPATOCELLULAR CARCINOMA [neop]    
Pre-existing [qlco]    
CIRRHOSIS [dsyn]    
Response [orga]    
Correlated [qlco]    
Mortality [qnco]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
secondary [neop]    
Combination Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Survival [acty]    
Patients [podg]    
